Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6

Details 詳細情報について

• CRID

  1363951795195934080

• DOI

  10.1016/s1470-2045(15)00026-1

• ISSN

  14702045

• Web Site

  https://api.elsevier.com/content/article/PII:S1470204515000261?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1470204515000261?httpAccept=text/plain

• Data Source

  • Crossref